š”š²šš š¦ššŗšŗš®šæš
ā¢ Zydus Lifesciences reported a 53.2% growth in consolidated net profit for the July-September quarter of FY 2023-2024.
ā¢ Revenue for the quarter was 5.6% higher than the previous fiscal year.
ā¢ The company's bottomline and revenue have both shown significant growth compared to the same period last year.